Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,414 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Body weight loss is a simple and useful indicator of prognosis and predictive tolerability in the first year of nintedanib therapy in patients with interstitial lung disease.
Yamakawa H, Sato S, Ohta H, Kusano K, Kawabe R, Oba T, Uzuka C, Sasaki H, Akasaka K, Amano M, Takemura T, Araya J, Matsushima H. Yamakawa H, et al. Among authors: ohta h. Respir Investig. 2024 Apr 24;62(4):551-557. doi: 10.1016/j.resinv.2024.04.011. Online ahead of print. Respir Investig. 2024. PMID: 38663299
Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer.
Sato S, Oba T, Ohta H, Tsukahara Y, Kida G, Tsumiyama E, Kusano K, Nishizawa T, Kawabe R, Yamakawa H, Akasaka K, Amano M, Matsushima H. Sato S, et al. Among authors: ohta h. Respir Med Case Rep. 2020 Sep 28;31:101241. doi: 10.1016/j.rmcr.2020.101241. eCollection 2020. Respir Med Case Rep. 2020. PMID: 33024691 Free PMC article.
Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report.
Yamakawa H, Oba T, Ohta H, Tsukahara Y, Kida G, Tsumiyama E, Nishizawa T, Kawabe R, Sato S, Akasaka K, Amano M, Kuwano K, Matsushima H. Yamakawa H, et al. Among authors: ohta h. BMC Pulm Med. 2019 Aug 22;19(1):156. doi: 10.1186/s12890-019-0920-9. BMC Pulm Med. 2019. PMID: 31438923 Free PMC article.
A case of pulmonary tumor thrombotic microangiopathy associated with lung cancer diagnosed by cell-block immunohistochemistry of pulmonary microvascular cytology.
Yamakawa H, Oba T, Ohta H, Tsukahara Y, Kida G, Tsumiyama E, Nishizawa T, Kawabe R, Sato S, Akasaka K, Amano M, Kuwano K, Matsushima H. Yamakawa H, et al. Among authors: ohta h. Respir Med Case Rep. 2019 Oct 23;28:100956. doi: 10.1016/j.rmcr.2019.100956. eCollection 2019. Respir Med Case Rep. 2019. PMID: 31720205 Free PMC article.
Nivolumab-induced contact dermatitis in a patient with advanced lung cancer.
Sato S, Oba T, Ohta H, Tsukahara Y, Kida G, Tsumiyama E, Kusano K, Nishizawa T, Kawabe R, Yamakawa H, Akasaka K, Amano M, Matsushima H. Sato S, et al. Among authors: ohta h. Respir Med Case Rep. 2020 Jun 15;30:101134. doi: 10.1016/j.rmcr.2020.101134. eCollection 2020. Respir Med Case Rep. 2020. PMID: 32577373 Free PMC article.
Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax.
Yamakawa H, Tsukahara Y, Sato S, Ohta H, Kida G, Nakamura T, Nishizawa T, Kawabe R, Oba T, Akasaka K, Amano M, Kuwano K, Sasaki H, Takemura T, Matsushima H. Yamakawa H, et al. Among authors: ohta h. Sarcoidosis Vasc Diffuse Lung Dis. 2022;38(4):e2021042. doi: 10.36141/svdld.v38i4.11465. Epub 2022 Jan 13. Sarcoidosis Vasc Diffuse Lung Dis. 2022. PMID: 35115749 Free PMC article.
2,414 results